Opportunity

Simpler Grants.gov #PAR-24-321

NIH Grant for Academic Leadership in Aging and Alzheimer's Disease Research

Buyer

National Institutes of Health

Posted

November 06, 2024

Respond By

November 12, 2027

Identifier

PAR-24-321

NAICS

541715

This opportunity from the National Institutes of Health (NIH) seeks to support academic leadership in aging and Alzheimer's Disease research: - Government Buyer: - National Institutes of Health (NIH), under Assistance Listing 93.866 for Aging Research - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a grant for research and educational activities - Products/Services Requested: - Funding for research and educational infrastructure development - Activities may include: courses, curricula, research support, pilot funding, travel awards, visiting scholars, or research networks - Focus on mentorship and career development in aging and Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD) - Unique or Notable Requirements: - Leading independent clinical trials is not allowed - Participation in clinical trials led by others is permitted - Eligible applicants include government agencies, educational institutions, nonprofits, businesses, HBCUs, tribal organizations, and U.S. territories - No specific products, part numbers, or quantities are requested, as this is a grant opportunity, not a product procurement

Description

The NIA Academic Leadership Career Award (K07) supports established investigators with expertise and leadership skills to enhance aging and Alzheimer's Disease research capacity within their academic institutions. The award facilitates development of research and educational infrastructure, mentorship, and career development activities in new or emerging areas of aging and Alzheimer's Disease research. Proposed activities may include courses, curricula, research support, pilot funding, travel awards, visiting scholars, or networks. This funding opportunity is specifically for research that does not involve leading an independent clinical trial, clinical trial feasibility study, or ancillary clinical trial, though participation in clinical trials led by others is permitted.

View original listing